| Alembic Pharmaceuticals Ltd | 13,308 Cr. | 677 | 1,108/635 | 20.1 | 271 | 1.62 % | 13.0 % | 11.4 % | 2.00 |
| Jubilant Pharmova Ltd | 13,008 Cr. | 817 | 1,250/784 | 28.2 | 414 | 0.61 % | 9.54 % | 9.55 % | 1.00 |
| Caplin Point Laboratories Ltd | 11,935 Cr. | 1,570 | 2,397/1,500 | 19.4 | 416 | 0.38 % | 25.8 % | 22.7 % | 2.00 |
| Cohance Lifesciences Ltd | 11,934 Cr. | 312 | 1,250/267 | 39.7 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Granules India Ltd | 15,242 Cr. | 628 | 640/412 | 28.0 | 164 | 0.24 % | 15.1 % | 13.9 % | 1.00 |
| Concord Biotech Ltd | 10,671 Cr. | 1,020 | 2,150/990 | 33.6 | 174 | 1.05 % | 28.4 % | 21.4 % | 1.00 |
| Neuland Laboratories Ltd | 16,182 Cr. | 12,613 | 19,748/10,060 | 90.3 | 1,263 | 0.10 % | 18.7 % | 14.8 % | 10.0 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Natco Pharma Ltd | 17,945 Cr. | 1,002 | 1,060/660 | 11.5 | 483 | 0.60 % | 32.8 % | 28.0 % | 2.00 |
| ERIS Lifesciences Ltd | 18,152 Cr. | 1,310 | 1,910/1,097 | 40.9 | 227 | 0.56 % | 12.2 % | 12.9 % | 1.00 |
| Procter & Gamble Health Ltd | 7,983 Cr. | 4,809 | 6,739/4,725 | 27.2 | 373 | 2.60 % | 47.8 % | 36.4 % | 10.0 |
| Marksans Pharma Ltd | 7,615 Cr. | 168 | 271/155 | 21.1 | 59.3 | 0.48 % | 20.0 % | 16.8 % | 1.00 |
| Acutaas Chemicals Ltd | 19,093 Cr. | 2,332 | 2,688/930 | 66.5 | 173 | 0.06 % | 19.9 % | 16.0 % | 5.00 |
| Sanofi India Ltd | 7,513 Cr. | 3,262 | 6,718/3,151 | 21.7 | 326 | 2.30 % | 57.5 % | 43.0 % | 10.0 |
| Shilpa Medicare Ltd | 7,328 Cr. | 375 | 502/260 | 41.4 | 125 | 0.13 % | 7.82 % | 4.21 % | 1.00 |
| Astrazeneca Pharma India Ltd | 19,630 Cr. | 7,852 | 10,691/6,502 | 94.4 | 320 | 0.41 % | 33.4 % | 23.6 % | 2.00 |
| Blue Jet Healthcare Ltd | 6,089 Cr. | 351 | 1,028/325 | 20.7 | 72.4 | 0.34 % | 39.8 % | 30.2 % | 2.00 |
| Wockhardt Ltd | 20,598 Cr. | 1,268 | 1,870/1,087 | 190 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Aarti Pharmalabs Ltd | 5,757 Cr. | 635 | 972/557 | 26.7 | 226 | 0.79 % | 17.4 % | 14.5 % | 5.00 |
| Entero Healthcare Solutions Ltd | 5,424 Cr. | 1,247 | 1,511/944 | 46.6 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| FDC Ltd | 5,345 Cr. | 328 | 528/313 | 23.0 | 149 | 1.52 % | 15.9 % | 11.8 % | 1.00 |
| Pfizer Ltd | 22,201 Cr. | 4,853 | 5,993/3,701 | 29.2 | 841 | 0.72 % | 21.6 % | 16.4 % | 10.0 |
| Suven Life Sciences Ltd | 3,888 Cr. | 147 | 303/115 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Zota Health Care Ltd | 3,802 Cr. | 1,116 | 1,740/752 | | 93.5 | 0.09 % | 17.0 % | 36.0 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,678 Cr. | 393 | 434/175 | 42.1 | 81.2 | 0.10 % | 12.2 % | 11.0 % | 1.00 |
| Aarti Drugs Limited | 3,162 Cr. | 346 | 575/312 | 17.0 | 147 | 0.58 % | 13.5 % | 13.0 % | 10.0 |
| RPG Life Sciences Ltd | 3,105 Cr. | 1,878 | 2,725/1,731 | 29.6 | 335 | 1.07 % | 32.8 % | 25.5 % | 8.00 |
| Advanced Enzyme Technologies Ltd | 2,981 Cr. | 266 | 367/252 | 20.7 | 133 | 1.95 % | 13.1 % | 9.54 % | 2.00 |
| Gufic BioSciences Ltd | 2,895 Cr. | 289 | 409/268 | 57.3 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Gujarat Themis Biosyn Ltd | 2,692 Cr. | 247 | 479/222 | 56.3 | 24.3 | 0.27 % | 27.3 % | 21.7 % | 1.00 |
| Orchid Pharma Ltd | 2,634 Cr. | 519 | 899/471 | 101 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Bliss GVS Pharma Ltd | 2,427 Cr. | 229 | 244/105 | 22.0 | 107 | 0.22 % | 11.7 % | 8.36 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 2,291 Cr. | 146 | 322/128 | 17.4 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,273 Cr. | 77.4 | 127/57.5 | 18.2 | 59.7 | 1.29 % | 8.86 % | 6.13 % | 2.00 |
| Unichem Laboratories Ltd | 2,100 Cr. | 298 | 712/278 | 20.0 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| Morepen Laboratories Ltd | 2,038 Cr. | 37.2 | 70.5/33.0 | 26.7 | 21.8 | 0.54 % | 15.1 % | 11.8 % | 2.00 |
| Solara Active Pharma Sciences Ltd | 2,023 Cr. | 459 | 734/422 | | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| Panacea Biotec Ltd | 1,992 Cr. | 325 | 582/292 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Hikal Ltd | 1,972 Cr. | 160 | 457/146 | 78.9 | 96.9 | 0.88 % | 9.85 % | 7.38 % | 2.00 |
| Indoco Remedies Ltd | 1,727 Cr. | 187 | 350/162 | | 106 | 0.11 % | 0.49 % | 7.02 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,457 Cr. | 1,404 | 1,740/666 | 25.5 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Amrutanjan Health Care Ltd | 1,444 Cr. | 500 | 791/486 | 25.0 | 118 | 0.92 % | 22.4 % | 16.5 % | 1.00 |
| Beta Drugs Ltd | 1,287 Cr. | 1,270 | 2,000/990 | 29.9 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Jagsonpal Pharmaceuticals Ltd | 1,243 Cr. | 186 | 302/155 | 29.2 | 37.9 | 1.35 % | 23.0 % | 18.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,191 Cr. | 595 | 679/440 | 13.6 | 357 | 0.30 % | 17.3 % | 12.8 % | 10.0 |
| Hester Biosciences Ltd | 1,162 Cr. | 1,366 | 2,350/1,239 | 28.4 | 397 | 0.51 % | 9.71 % | 9.18 % | 10.0 |
| Venus Remedies Ltd | 1,151 Cr. | 861 | 950/286 | 15.1 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Ind-Swift Laboratories Ltd | 1,128 Cr. | 138 | 152/67.2 | 23.8 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| TTK Healthcare Ltd | 1,107 Cr. | 784 | 1,402/735 | 15.9 | 768 | 1.28 % | 9.26 % | 6.89 % | 10.0 |
| Syncom Formulations (India) Ltd | 1,050 Cr. | 11.2 | 23.5/10.2 | 15.2 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Fermenta Biotech Ltd | 965 Cr. | 328 | 399/241 | 10.9 | 133 | 0.76 % | 23.0 % | 24.9 % | 5.00 |
| Fredun Pharmaceuticals Ltd | 939 Cr. | 1,716 | 1,999/635 | 27.6 | 294 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Wanbury Ltd | 805 Cr. | 230 | 330/162 | 18.7 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Anuh Pharma Ltd | 731 Cr. | 73.0 | 115/66.7 | 17.5 | 32.6 | 2.06 % | 17.2 % | 13.4 % | 5.00 |
| Themis Medicare Ltd | 683 Cr. | 74.2 | 179/65.0 | | 41.3 | 0.67 % | 10.4 % | 7.65 % | 1.00 |
| Kopran Ltd | 574 Cr. | 119 | 215/107 | 34.7 | 104 | 2.53 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 484 Cr. | 138 | 250/117 | 18.6 | 75.9 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Albert David Ltd | 352 Cr. | 616 | 959/580 | 36.6 | 690 | 0.81 % | 6.45 % | 4.39 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 265 Cr. | 112 | 205/70.6 | 23.1 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| BDH Industries Ltd | 219 Cr. | 381 | 524/241 | 21.0 | 123 | 1.18 % | 17.8 % | 14.2 % | 10.0 |
| Everest Organics Ltd | 215 Cr. | 221 | 536/197 | 36.7 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Gennex Laboratories Ltd | 208 Cr. | 8.55 | 17.2/7.05 | 11.9 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Nectar Lifescience Ltd | 190 Cr. | 9.76 | 28.3/9.20 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Lyka Labs Ltd | 183 Cr. | 51.2 | 129/44.1 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Auro Laboratories Ltd | 169 Cr. | 272 | 317/159 | 57.4 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Aarey Drugs & Pharmaceuticals Ltd | 151 Cr. | 53.3 | 100/41.1 | 44.0 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Coral Laboratories Ltd | 137 Cr. | 383 | 785/360 | 9.57 | 596 | 0.39 % | 17.4 % | 13.1 % | 10.0 |
| Achyut Healthcare Ltd | 132 Cr. | 5.62 | 6.80/3.00 | 308 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Brooks Laboratories Ltd | 131 Cr. | 44.5 | 166/36.3 | 6.07 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 120 Cr. | 82.1 | 82.1/17.0 | 481 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Lactose (India) Ltd | 106 Cr. | 84.2 | 137/76.0 | 21.9 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| Alpa Laboratories Ltd | 106 Cr. | 50.2 | 120/46.0 | 8.95 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Bal Pharma Ltd | 103 Cr. | 64.9 | 129/59.7 | 12.7 | 49.2 | 1.85 % | 10.1 % | 9.66 % | 10.0 |
| Par Drugs & Chemicals Ltd | 102 Cr. | 82.6 | 122/78.0 | 7.31 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 101 Cr. | 28.6 | 73.4/27.1 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Gland Pharma Ltd | 28,107 Cr. | 1,706 | 2,131/1,200 | 23.7 | 610 | 1.06 % | 15.8 % | 11.6 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 32,253 Cr. | 2,009 | 2,195/1,303 | 42.8 | 243 | 0.77 % | 25.8 % | 20.1 % | 1.00 |
| Ajanta Pharma Ltd | 35,192 Cr. | 2,817 | 3,228/2,022 | 34.7 | 345 | 0.99 % | 32.4 % | 24.9 % | 2.00 |
| Ipca Laboratories Ltd | 38,264 Cr. | 1,508 | 1,624/1,168 | 36.2 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 39,458 Cr. | 2,329 | 3,516/2,218 | 39.2 | 101 | 1.80 % | 63.2 % | 46.9 % | 10.0 |
| Laurus Labs Ltd | 56,080 Cr. | 1,039 | 1,141/517 | 70.0 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Abbott India Ltd | 56,291 Cr. | 26,490 | 37,000/25,350 | 36.9 | 1,888 | 1.79 % | 46.2 % | 35.7 % | 10.0 |
| Biocon Ltd | 59,196 Cr. | 365 | 425/295 | 72.1 | 200 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Glenmark Life Sciences Ltd | 59,293 Cr. | 2,101 | 2,298/1,336 | 21.9 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 59,293 Cr. | 2,101 | 2,298/1,336 | 21.9 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Alkem Laboratories Ltd | 62,655 Cr. | 5,244 | 5,934/4,612 | 26.1 | 1,116 | 0.86 % | 20.4 % | 19.4 % | 2.00 |
| Aurobindo Pharma Ltd | 77,949 Cr. | 1,342 | 1,360/994 | 22.1 | 603 | 0.30 % | 14.2 % | 11.1 % | 1.00 |
| Mankind Pharma Ltd | 82,619 Cr. | 2,001 | 2,727/1,910 | 46.8 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| Cipla Ltd | 96,603 Cr. | 1,196 | 1,673/1,194 | 20.3 | 408 | 1.09 % | 22.7 % | 17.8 % | 2.00 |
| Dr Reddys Laboratories Ltd | 1,00,960 Cr. | 1,210 | 1,380/1,020 | 18.1 | 432 | 0.66 % | 22.7 % | 18.0 % | 1.00 |
| Lupin Ltd | 1,04,004 Cr. | 2,275 | 2,378/1,774 | 20.9 | 430 | 0.53 % | 21.3 % | 20.6 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,39,145 Cr. | 4,111 | 4,483/3,101 | 60.4 | 250 | 0.78 % | 27.0 % | 26.5 % | 5.00 |
| Sun Pharmaceuticals Industries Ltd | 4,14,725 Cr. | 1,728 | 1,851/1,547 | 34.2 | 324 | 0.93 % | 20.2 % | 16.9 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 44.8 Cr. | 27.6 | 57.2/25.6 | 16.2 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Fervent Synergies Ltd | 91.3 Cr. | 18.3 | 29.8/16.0 | 26.5 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Godavari Drugs Ltd | 94.0 Cr. | 92.8 | 115/69.7 | 26.8 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Checkpoint Trends Ltd | 25.0 Cr. | 45.8 | 144/14.7 | 12.2 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Dipna Pharmachem Ltd | 24.3 Cr. | 9.25 | 26.3/7.45 | 11.9 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Colinz Laboratories Ltd | 5.79 Cr. | 46.0 | 87.9/36.1 | 11.8 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 19.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Evoq Remedies Ltd | 6.27 Cr. | 2.52 | 6.11/2.30 | 3.56 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 1.12/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Chandra Bhagat Pharma Ltd | 24.1 Cr. | 32.0 | 61.5/30.0 | 38.9 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Amerise Biosciences Ltd | 4.03 Cr. | 0.61 | 0.97/0.50 | 57.6 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.35 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Bacil Pharma Ltd | 71.9 Cr. | 50.1 | 51.9/26.7 | 97.2 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Concord Drugs Ltd | 70.6 Cr. | 70.6 | 92.5/29.0 | 133 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Adline Chem Lab Ltd | 7.31 Cr. | 12.5 | 19.1/7.60 | 244 | 2.75 | 0.00 % | % | % | 10.0 |
| Beryl Drugs Ltd | 9.63 Cr. | 19.0 | 30.0/15.9 | 963 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| MPS Pharmaa Ltd | 3.15 Cr. | 1.65 | 3.17/1.57 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 25.3 Cr. | 32.5 | 68.4/29.0 | | 10.1 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Fabino Enterprises Ltd | 3.35 Cr. | 15.9 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Decipher Labs Ltd | 5.28 Cr. | 5.23 | 12.5/5.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.99 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 17.4 Cr. | 116 | 153/75.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Brawn Biotech Ltd | 6.26 Cr. | 20.8 | 24.4/15.7 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Bharat Immunological & Biological Corporation Ltd | 68.0 Cr. | 15.8 | 28.8/14.1 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| ANG Lifesciences India Ltd | 26.5 Cr. | 20.3 | 39.7/17.6 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Vivimed Labs Ltd | 45.8 Cr. | 5.53 | 29.4/5.15 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Mangalam Drugs and Organics Ltd | 45.1 Cr. | 28.5 | 95.0/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Industry Average | 19,815.15 Cr | 1,053.84 | | 53.84 | 201.20 | 0.39% | 16.35% | 15.16% | 6.10 |